A
Aardvark Therapeutics, Inc. (AARD)
NMS – Real Time Price. Currency in USD
6.11
+0.39 (6.82%)
At close: May 12, 2026, 4:00 PM EDT
6.00
-0.11 (-1.80%)
Pre-market: May 13, 2026, 7:40 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.11
+0.39 (6.82%)
At close: May 12, 2026, 4:00 PM EDT
6.00
-0.11 (-1.80%)
Pre-market: May 13, 2026, 7:40 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $62.4M significantly exceed its total debt $336.0K, ensuring strong financial flexibility
Total current assets $93.6M exceed Total current liabilities $11.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$18.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.06 | 6.05 | 10 | |
| Quick ratio | 8.06 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -110K | -97K | -16K | -36K | -42K |
| Operating Income | -11M | -7M | -23M | -63M | -75M |
| Net Income | -14M | -7M | -21M | -58M | -70M |
| EBITDA | -11M | -7M | -23M | -63M | -75M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -31.57 | 1.0 |
| Next quarter | N/A | -15.67 | 1.0 |
| Current year | N/A | -22.1 | 1.0 |
| Next year | N/A | 7.27 | 3.0 |
| Weighted average score | 1.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -22.66 | -22.21 | -30.82 | 3.3 |
| Y/Y | 999 | -131.87 | -39.43 | -65.68 | 3.3 |
| 3y average | 999 | -106.15 | N/A | -122.67 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |